News & Events

Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy

September 19, 2011

PALO ALTO, CA and SEATTLE, WAVarian Medical Systems, Inc., (NYSE:VAR) and Calypso Medical Technologies, Inc., today announced they have signed a definitive agreement under which Varian will acquire Calypso, a privately-owned, Seattle-based developer and supplier of specialized products and software for real-time tumor tracking and motion management during radiosurgery and radiotherapy. Read More…

Platelet Reactivity Testing Included in 2011 Guideline Recommendations from European Society of Cardiology

September 7, 2011

Clinical Role of Platelet Reactivity Testing Gains Additional Support with Third Guideline Recommendation by a Medical Society in 2011

SAN DIEGO, CAAccumetrics, Inc., developer of the VerifyNow® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced today that a new recommendation (IIb-B) to consider platelet function testing has been incorporated in the European Society of Cardiology (ESC) Guidelines. Read More…

New Data Underscores Importance of Platelet Reactivity Testing to Aid in Risk Assessment

August 29, 2011

Following Stent Placement, Low Platelet Reactivity at Time of Discharge and After 30 Days Leads to 50% Reduction in Cardiovascular Events

SAN DIEGO, CA – Data announced today at the European Society of Cardiology (ESC) Congress in Paris and simultaneously published in Circulation1 show that stent patients exhibited a 50% reduction in cardiovascular death, heart attack and stent thrombosis over 6 months when they achieved low platelet reactivity, as measured by the Accumetrics’ VerifyNow P2Y12 Test, at discharge and 30 days post-procedure. The VerifyNow P2Y12 Test is used to measure a patient’s platelet reactivity and the antiplatelet effect of medications such as clopidogrel or prasugrel (Plavix® and Effient®). Read More…

Centerre Healthcare Corporation and Mercy Health Center Announce New Rehab Hospital

August 19, 2011

August 16 groundbreaking celebrated for 50-bed, 50,000-square-foot facility

NASHVILLE, TENNESSEE and OKLAHOMA CITY, OKLAHOMA Mercy Health Center, in partnership with Nashville based Centerre Healthcare Corporation – a national leader in the development and operation of rehabilitation hospitals, broke ground this past Tuesday for the construction of the 50,000-square-foot comprehensive Mercy Rehabilitation Hospital. Read More…